Loading...

We've got a brand new version of Simply Wall St! Try it out

Green Thumb Industries

CNSX:GTII
Snowflake Description

High growth potential with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
GTII
CNSX
CA$3B
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Green Thumb Industries Inc. manufactures, distributes, and sells various cannabis products for medical and adult-use in the United States. The last earnings update was 25 days ago. More info.


Add to Portfolio Compare Print
GTII Share Price and Events
7 Day Returns
7.5%
CNSX:GTII
-5.9%
CA Pharmaceuticals
1.3%
CA Market
1 Year Returns
-48.9%
CNSX:GTII
-46.7%
CA Pharmaceuticals
-0.1%
CA Market
GTII Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Green Thumb Industries (GTII) 7.5% 28.7% -1.2% -48.9% - -
CA Pharmaceuticals -5.9% -3.4% -24.8% -46.7% 217.3% 286.4%
CA Market 1.3% 4.2% 1.6% -0.1% 8.4% 5.7%
1 Year Return vs Industry and Market
  • GTII underperformed the Pharmaceuticals industry which returned -46.7% over the past year.
  • GTII underperformed the Market in Canada which returned -0.1% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

GTII Value

 Is Green Thumb Industries undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Green Thumb Industries to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Green Thumb Industries.

CNSX:GTII Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 14 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.8%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for CNSX:GTII
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.7
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.698 (1 + (1- 21%) (5.52%))
0.818
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.82
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (0.818 * 5.96%)
6.82%

Discounted Cash Flow Calculation for CNSX:GTII using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Green Thumb Industries is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

CNSX:GTII DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 6.82%)
2020 -25.71 Analyst x3 -24.07
2021 104.79 Analyst x2 91.83
2022 174.53 Est @ 66.56% 143.17
2023 256.86 Est @ 47.17% 197.26
2024 343.19 Est @ 33.61% 246.71
2025 425.92 Est @ 24.11% 286.63
2026 500.29 Est @ 17.46% 315.17
2027 564.36 Est @ 12.81% 332.82
2028 618.25 Est @ 9.55% 341.31
2029 663.18 Est @ 7.27% 342.73
Present value of next 10 years cash flows $2,273.00
CNSX:GTII DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $663.18 × (1 + 1.95%) ÷ (6.82% – 1.95%)
$13,863.50
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $13,863.50 ÷ (1 + 6.82%)10
$7,164.62
CNSX:GTII Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $2,273.00 + $7,164.62
$9,437.62
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $9,437.62 / 217.87
$43.32
CNSX:GTII Discount to Share Price
Calculation Result
Exchange Rate USD/CAD
(Reporting currency to currency of CNSX:GTII)
1.326
Value per Share
(CAD)
= Value per Share in USD x Exchange Rate (USD/CAD)
= $43.32 x 1.326
CA$57.45
Value per share (CAD) From above. CA$57.45
Current discount Discount to share price of CA$13.58
= -1 x (CA$13.58 - CA$57.45) / CA$57.45
76.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Green Thumb Industries is available for.
Intrinsic value
>50%
Share price is CA$13.58 vs Future cash flow value of CA$57.45
Current Discount Checks
For Green Thumb Industries to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Green Thumb Industries's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Green Thumb Industries's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Green Thumb Industries's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Green Thumb Industries's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:GTII PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-0.23
CNSX:GTII Share Price ** CNSX (2019-09-20) in CAD CA$13.58
CNSX:GTII Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $10.24
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 15.3x
Canada Market PE Ratio Median Figure of 539 Publicly-Listed Companies 14.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Green Thumb Industries.

CNSX:GTII PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:GTII Share Price ÷ EPS (both in USD)

= 10.24 ÷ -0.23

-44.63x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Green Thumb Industries is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Green Thumb Industries is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Green Thumb Industries's expected growth come at a high price?
Raw Data
CNSX:GTII PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -44.63x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 14 Analysts
117.2%per year
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.56x
Canada Market PEG Ratio Median Figure of 245 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Green Thumb Industries, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Green Thumb Industries's assets?
Raw Data
CNSX:GTII PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $4.10
CNSX:GTII Share Price * CNSX (2019-09-20) in CAD CA$13.58
CNSX:GTII Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $10.24
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.36x
Canada Market PB Ratio Median Figure of 2,457 Publicly-Listed Companies 1.43x
CNSX:GTII PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:GTII Share Price ÷ Book Value per Share (both in USD)

= 10.24 ÷ 4.10

2.5x

* Primary Listing of Green Thumb Industries.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Green Thumb Industries is overvalued based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Green Thumb Industries's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Green Thumb Industries has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

GTII Future Performance

 How is Green Thumb Industries expected to perform in the next 1 to 3 years based on estimates from 14 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
117.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Green Thumb Industries expected to grow at an attractive rate?
  • Green Thumb Industries's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
  • Green Thumb Industries's earnings growth is expected to exceed the Canada market average.
  • Green Thumb Industries's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
CNSX:GTII Future Growth Rates Data Sources
Data Point Source Value (per year)
CNSX:GTII Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 14 Analysts 117.2%
CNSX:GTII Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 14 Analysts 51.5%
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 97.7%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 56.5%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:GTII Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 14 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:GTII Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 984 1
2021-12-31 738 143 92 7
2020-12-31 485 82 59 13
2019-12-31 213 15 -50 14
2019-09-22
CNSX:GTII Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 111 -1 -39
2019-03-31 79 -9 -16
2018-12-31 62 -7 -8
2018-09-30 48 -11 -7
2018-06-30 35 -15 -5
2018-03-31 24 -6 -7
2017-12-31 17 -4 -4
2016-12-31 7 -3 -3

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Green Thumb Industries's earnings are expected to grow significantly at over 20% yearly.
  • Green Thumb Industries's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:GTII Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 14 Analyst Estimates (S&P Global) See Below

All data from Green Thumb Industries Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:GTII Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31
2021-12-31 0.21 0.28 0.14 2.00
2020-12-31 0.07 0.35 -0.31 7.00
2019-12-31 -0.26 -0.11 -0.36 7.00
2019-09-22
CNSX:GTII Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -0.23
2019-03-31 -0.09
2018-12-31 -0.05
2018-09-30 -0.05
2018-06-30 -0.04
2018-03-31
2017-12-31
2016-12-31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Green Thumb Industries is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Green Thumb Industries's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Green Thumb Industries has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

GTII Past Performance

  How has Green Thumb Industries performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Green Thumb Industries's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Green Thumb Industries does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Green Thumb Industries's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Green Thumb Industries's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Green Thumb Industries's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Green Thumb Industries Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:GTII Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 110.58 -38.61 85.13
2019-03-31 79.48 -15.97 70.28
2018-12-31 62.49 -7.86 53.02
2018-09-30 47.89 -6.92 31.62
2018-06-30 34.58 -4.82 24.18
2018-03-31 24.44 -6.54 15.08
2017-12-31 16.53 -3.74 11.23
2016-12-31 7.21 -3.10 4.59

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Green Thumb Industries has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Green Thumb Industries has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Green Thumb Industries improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Green Thumb Industries's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Green Thumb Industries has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

GTII Health

 How is Green Thumb Industries's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Green Thumb Industries's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Green Thumb Industries is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Green Thumb Industries's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Green Thumb Industries's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Green Thumb Industries Company Filings, last reported 2 months ago.

CNSX:GTII Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 821.37 96.31 135.76
2019-03-31 534.88 6.73 117.08
2018-12-31 348.88 7.21 145.99
2018-09-30 274.99 7.56 149.77
2018-06-30 210.41 7.91 112.65
2018-03-31 81.58 16.57 38.92
2017-12-31 65.37 16.07 29.57
2016-12-31 31.86 2.00 12.96
  • Green Thumb Industries's level of debt (11.7%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Green Thumb Industries's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Green Thumb Industries has sufficient cash runway for 2.4 years based on current free cash flow.
  • Unable to confirm if Green Thumb Industries has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess Green Thumb Industries's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Green Thumb Industries has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

GTII Dividends

 What is Green Thumb Industries's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Green Thumb Industries dividends.
If you bought CA$2,000 of Green Thumb Industries shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Green Thumb Industries's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Green Thumb Industries's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:GTII Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 14 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:GTII Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-12-31
2021-12-31
2020-12-31
2019-12-31
2019-09-22

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Green Thumb Industries has not reported any payouts.
  • Unable to verify if Green Thumb Industries's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Green Thumb Industries's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Green Thumb Industries has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Green Thumb Industries's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Green Thumb Industries afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Green Thumb Industries has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

GTII Management

 What is the CEO of Green Thumb Industries's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ben Kovler
AGE 40
TENURE AS CEO 1.1 years
CEO Bio

Mr. Benjamin Kovler, also known as Ben, serves as Chairman at Green Thumb Industries Inc. and has been its Director since July 2017. He is Founder of Green Thumb Industries Inc. He also serves as CEO at Green Thumb Industries Inc. since August 29, 2018. Mr. Kovler brings his extensive experience managing complex operating companies and his deep commitment to philanthropy as Chairman of GTI. Ben founded GTI in 2014 and has successfully scaled it into a national cannabis consumer packaged goods Corporation and retail dispensary chain with 53 licenses across six highly-regulated U.S. markets. Additionally, Ben is the Chief Investment Officer for Kovpak II, LLC, an investment partnership that allocates capital into public and private markets across a wide range of industries. He is also co-founder and CEO of Invest For Kids (IFK). He earned a Bachelor of Arts in philosophy, politics and economics from Pomona College and an M.B.A. in accounting and finance from The University of Chicago. He also taught 8th grade math and published a book of brain teasers and puzzles.

CEO Compensation
  • Insufficient data for Ben to compare compensation growth.
  • Insufficient data for Ben to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the Green Thumb Industries management team in years:

0.7
Average Tenure
43
Average Age
  • The average tenure for the Green Thumb Industries management team is less than 2 years, this suggests a new team.
Management Team

Ben Kovler

TITLE
Founder
AGE
40
TENURE
1.1 yrs

Anthony Georgiadis

TITLE
CFO & Director
AGE
41

Andy Grossman

TITLE
EVP of Capital Markets & Investor Relations
AGE
45

Dina Rollman

TITLE
Chief Compliance Counsel
AGE
46

Matt Miller

TITLE
General Counsel
TENURE
0.7 yrs

Linda Marsicano

TITLE
Vice President of Communications
AGE
51

Daniel Shaker

TITLE
Vice President of Sales
AGE
48

Kate Denton

TITLE
Senior Vice President of Marketing
TENURE
0.7 yrs

Eunice kim

TITLE
Vice President of People & Culture
AGE
31

Bret Kravitz

TITLE
Chief Corporate Counsel
AGE
38
Board of Directors Tenure

Average tenure and age of the Green Thumb Industries board of directors in years:

1.3
Average Tenure
53
Average Age
  • The average tenure for the Green Thumb Industries board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ben Kovler

TITLE
Founder
AGE
40
TENURE
2.2 yrs

Anthony Georgiadis

TITLE
CFO & Director
AGE
41
TENURE
2.2 yrs

Wendy Berger

TITLE
Non Executive Director
AGE
53
TENURE
2.2 yrs

Bill Gruver

TITLE
Non Executive Director
AGE
74
TENURE
0.4 yrs

Glen Senk

TITLE
Non Executive Director
AGE
63
TENURE
1.3 yrs

Wes Moore

TITLE
Non Executive Director
AGE
41
TENURE
1.2 yrs

Alex Yemenidjian

TITLE
Director
AGE
63
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • Green Thumb Industries individual insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
10. Sep 19 Sell The Kadens Family Foundation,Endowment Arm Company 05. Sep 19 05. Sep 19 -25,000 CA$12.20 CA$-305,000
10. Sep 19 Sell Peter Kadens Individual 10. Sep 19 10. Sep 19 -125,000 CA$13.04 CA$-1,630,000
22. Aug 19 Buy Yemenidjian Living Trust Company 12. Aug 19 12. Aug 19 108,649 CA$13.33 CA$1,448,291
22. Aug 19 Buy Armen Yemenidjian Individual 12. Aug 19 12. Aug 19 119,223 CA$13.33 CA$1,589,243
26. Jul 19 Sell Kadens Family Holdings, Llc Company 22. Jul 19 26. Jul 19 -84,500 CA$12.75 CA$-1,017,718
19. Jul 19 Sell Kadens Family Holdings, Llc Company 15. Jul 19 19. Jul 19 -171,300 CA$12.92 CA$-2,109,051
12. Jul 19 Sell Kadens Family Holdings, Llc Company 08. Jul 19 12. Jul 19 -65,900 CA$13.81 CA$-868,853
08. Jul 19 Sell Kadens Family Holdings, Llc Company 03. Jul 19 05. Jul 19 -30,100 CA$14.44 CA$-426,592
03. Jul 19 Sell Kadens Family Holdings, Llc Company 17. Jun 19 02. Jul 19 -186,600 CA$14.74 CA$-2,558,049
24. Jun 19 Buy Armen Yemenidjian Individual 21. Jun 19 21. Jun 19 99,818 CA$15.16 CA$1,513,241
21. Jun 19 Buy Yemenidjian Living Trust Company 21. Jun 19 21. Jun 19 90,965 CA$15.16 CA$1,379,029
17. Jun 19 Sell Kadens Family Holdings, Llc Company 12. Jun 19 14. Jun 19 -47,400 CA$14.68 CA$-677,899
X
Management checks
We assess Green Thumb Industries's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Green Thumb Industries has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

GTII News

Simply Wall St News

When Will Green Thumb Industries Inc. (CNSX:GTII) Breakeven?

Green Thumb Industries Inc.'s (CNSX:GTII): Green Thumb Industries Inc. … View our latest analysis for Green Thumb Industries According to the 11 industry analysts covering GTII, the consensus is breakeven is near. … What rate will GTII have to grow year-on-year in order to breakeven on this date?

Simply Wall St -

Is Green Thumb Industries Inc. (CNSX:GTII) As Strong As Its Balance Sheet Indicates?

Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as Green Thumb Industries Inc. … Today we will look at GTII’s financial liquidity and debt levels, which are strong indicators for whether the company can weather economic downturns or fund strategic acquisitions for future growth. … Check out our latest analysis for Green Thumb Industries

Simply Wall St -

GTII Company Info

Description

Green Thumb Industries Inc. manufactures, distributes, and sells various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including concentrates, edibles, and topical and other cannabis products under the Rythm, Dogwalkers, The Feel Collection, Beboe, and other brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own Rise retail stores. As of August 13, 2019, it owned and operated 28 retail stores. It also had licenses for 95 locations across 12 U.S. markets. The company was founded in 2014 and is headquartered in Chicago, Illinois.

Details
Name: Green Thumb Industries Inc.
GTII
Exchange: CNSX
Founded: 2014
CA$2,958,685,260
217,870,785
Website: http://www.gtigrows.com
Address: Green Thumb Industries Inc.
325 West Huron Street,
Suite 412,
Chicago,
Illinois, 60654,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX GTII Subordinate Voting Shares Canadian National Stock Exchange CA CAD 13. Jun 2018
OTCPK GTBI.F Subordinate Voting Shares Pink Sheets LLC US USD 13. Jun 2018
Number of employees
Current staff
Staff numbers
1,200
Green Thumb Industries employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/22 00:44
End of day share price update: 2019/09/20 00:00
Last estimates confirmation: 2019/09/19
Last earnings filing: 2019/08/28
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.